Bulletin 153: Polypharmacy - Frailty

This bulletin focuses on frailty and end of life and the specific considertaions that would apply to this group of patients when reviewing medicines/considering stopping medicines. Medicines that should usually be continued and those with increased potential to cause harm are highlighted in the full bulletin with evidence-based tools to help the review process.

Loading...